Rescheduling could let DC legalize marijuana sales; MA anti-cannabis initiative challenge; Study: CBD combats tumors; OH’s $1 billion in sales
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today.
https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
The House of Representatives passed a spending bill containing a provision to continue protecting state medical cannabis laws from federal interference and without a separate rider that would have blocked the Trump administration from rescheduling marijuana.
Federal marijuana rescheduling in line with President Donald Trump’s recent executive order could have an outsized impact on Washington, D.C. by letting the city finally move forward with legalizing recreational cannabis sales—but there’s a possible catch.
The Massachusetts State Ballot Law Commission scheduled a hearing for next week to consider a complaint alleging that an anti-marijuana campaign for an initiative to roll back the state’s legalization law “obtained signatures fraudulently.”
A new scientific review concluded that “CBD exhibits multi-targeted anti-tumor effects by disrupting key cancer hallmarks.”
- “Cannabidiol…demonstrates promising antitumor effects by inhibiting cancer growth, metastasis, and angiogenesis, while also alleviating cancer-related symptoms such as pain and nausea.”
The Ohio Division of Cannabis Control reported that dispensaries sold more than $1 billion worth of legal recreational and medical marijuana products in 2025.
/ FEDERAL
The House bill to create a pathway for patients to use Schedule I drugs got one new cosponsor for a total of 12.
/ STATES
Kentucky Gov. Andy Beshear (D) noted the launch of medical cannabis sales in his State of the Commonwealth speech.
Washington, D.C. Mayor Muriel Bowser (D) touted the 100th closure of an unlicensed cannabis business since enforcement legislation went into effect.
A Virginia senator is resigning to take a position as senior advisor to the Cannabis Control Authority.
California regulators published guidance on avoiding cannabis business disputes.
Oklahoma regulators issued guidance on acceptable forms of medical cannabis patient ID.
Michigan regulators are accepting hemp grower registration applications.
Washington State regulators will host a feedback session on draft cannabis advertising rules on Friday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ INTERNATIONAL
British Columbia, Canada’s premier said the province is not considering decriminalizing public drug use when its current pilot project is up for renewal at the end of this month, though it’s not clear if officials will seek to extend drug decriminalization in any form.
The UK National Police Chiefs’ Council issued medical cannabis guidance.
/ SCIENCE & HEALTH
A study of rats found that “CBD demonstrates neuroprotective effects against blast-induced behavioral changes, with preventive administration more effective than post-injury treatment.”
A study suggested that “cannabinoids have distinct antibacterial effects on certain pathogens associated with persistent endodontic infections.”
A study of bread found that “10–15 % hemp flour offers optimal nutritional and technological balance.”
/ ADVOCACY, OPINION & ANALYSIS
Prohibitionist organization Smart Approaches to Marijuana published an “impact report.”
/ BUSINESS
Curaleaf Holdings, Inc. is moving to redomesticate to Delaware.
Canopy Growth Corporation entered into a series of transactions to recapitalize its balance sheet and extend the maturity dates of all outstanding indebtedness to January 2031 at the earliest.
Missouri retailers sold $124.8 million worth of legal marijuana products in November.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
